Celltrion unveiled its plan to build its third plant and a global biotechnology research center in Songdo, Incheon, during the Korea Bio-industry forum, on Wednesday.The company will build a 60,000-liter biopharmaceutical plant to build a multi-type production and supply system and a one-stop resear
The World Health Organization’s updated guidelines prioritizing immunization even during the prolonged Covid-19 pandemic are expected to help Korean cholera vaccine makers to win more orders, industry watchers said.On Nov. 10, the WHO announced the guidelines, titled, “Immunization as an essential h
The Korea Biotechnology Industry Organization (KoreaBio) welcomed the settlement of Regional Comprehensive Economic Partnership (RCEP) on Monday, saying it would serve as on occasion to let the world know the potential of the nation’s bio-industry. RCEP is a free trade agreement in the Asia-Pacific
GemVax & KAEL (GemVax) said Monday that it has released phase 2 clinical trial results of GV1001, its Alzheimer’s disease treatment.The company conducted clinical tests to evaluate the drug’s safety and efficacy at 12 local hospitals, including Hanyang University Guri Hospital, from August 2017 to S
Celltrion Group Chairman Seo Jeong-jin said Thursday that the group, now being run in three independent units, will become an integrated pharmaceutical company next year, and he will transfer its operational control to younger managers."It has been about 20 years since I founded Celltrion," Seo said
Samsung Bioepis will present the final of its phase 3 clinical trials of SB11, a Lucentis biosimilar, during the online conference of the American Academy of Ophthalmology (AAO) 2020 from Friday to Sunday.The company enrolled 705 patients in the phase 3 study and analyzed the results of 634 who comp
Bridge Biotherapeutics said the company has agreed to get the rights for BBT-877, a treatment candidate for idiopathic pulmonary fibrosis (IPF), from Boehringer Ingelheim.Bridge Biotherapeutics had hoped Boehringer Ingelheim would continue its research, but the multinational pharmaceutical decided t
Korean biotech companies are stepping up efforts to enter the global market of polydioxanone (PDO) threads used to lift sagging skin tissues, according to industry sources on Monday.PDO threads, used for PDO thread lifting, are naturally dissolved in the human body. PDO threads are widely used for v
Hugel has taken 80-percent equity of Jworld, a thread lifting fiber manufacturer, to expand its medical cosmetic business.Jworld manufactures various polydioxanone (PDO) threads using suture manufacturing techniques. The material used for stitching wounds and facelifts is made by only a few business
A local biotech firm obtained the regulatory approval for a diagnostic kit that detects the virus of the seasonal flu and Covid-19 simultaneously amid worries over “twindemic.”The Ministry of Food and Drug Safety granted the nod for Kogene Biotech’s product, “PowerChek™ SARS-CoV-2, Influenza A&B Mul
Samsung Biologics said that it would provide contract development organization (CDO) services to GeneQuantum, a Chinese bioventure.Under the accord, Samsung will give CDO support to developing GQ1003, GeneQuantum's treatment targeting non-small-cell lung carcinoma (NSCLC) and triple-negative breast
Samsung Biologics said that the company has opened a research and development center in San Francisco, Calif., to secure a bridgehead for growing into the world’s top contract development organization.Samsung Biologics decided to create its first overseas forward base in San Francisco, as the area i
Korean biotech companies are pinning their hopes on making connections and clinching licensing-out deals with multinational drugmakers at BIO-Europe Digital 2020.Since 1995, BIO-Europe has been an annual international event gathering global pharmaceutical companies from over 50 countries. The confer
Sillajen said Tuesday that the U.S. Food and Drug Administration has granted an orphan drug designation (ODD) to its skin cancer indication agent, Pexa-Vec. ODD is a system, which helps drugmakers develop and win the approval of treatments for rare diseases. After obtaining this authorization, the O
A consortium composed of Macrogen, DNA Link and Theragen Bio has commenced in earnest the “K-DNA project” to establish national bio big data, Macrogen said on Monday. The state project, jointly conducted by the Ministries of Health and Welfare, Science and ICT, and Trade, Industry and Energy, seeks
LG Chem said the company, together with its partner TransThhera Biosciences, has submitted an application to conduct the clinical trials of its NASH (non-alcoholic steatohepatitis) pipeline, TT-01025, to the U.S. Food and Drug Administration.NASH is a type of NAFLD (nonalcoholic fatty liver disease)
Samsung Biologics said the company’s sales and operating profit in the first three quarters have exceeded comparable figures for the whole of 2019.Thanks to higher capacity utilization rates of its factories and resultant cost cuts, the company recorded sales of 789.5 billion won ($690 million) and
Bio Eleven, a local biopharmaceutical company, said that it has signed a contract development organization (CDO) agreement with Samsung Biologics to receive the latter’s help in developing BN-101A, an immunotherapy candidate.Under the accord, Samsung Biologics will provide a full scope of its CDO se
Celltrion Healthcare recently signed a contract to supply its anticancer biosimilars -- Herzuma (ingredient: trastuzumab) and Truxima (ingredient: rituximab) -- to Brazil, the largest biopharmaceutical market in Latin America.Under the contract, Celltrion Healthcare will deliver Herzuma to Brazil’s
CancerRop, a molecular diagnostics company, said it obtained approval for a Covid-19 diagnostic kit, “Q-Sens® COVID-19 Detection Kit,” from the Ministry of Food and Drug Safety on Thursday.The authorized test kit uses a reverse transcription-polymerase chain reaction (RT-PCR) technique to detect the